Novo Nordisk's latest salvo against Hims & Hers—a patent-infringement lawsuit—shows the fierce maneuvering over the booming obesity-drug market
WSJ·2026-02-10 03:19

公司动态 - 丹麦制药公司正通过专利诉讼来巩固其在减肥药市场的地位 [1] 行业背景 - 减肥药市场正处于蓬勃发展阶段 [1]